DR. BRIAN E DAIKH MD NPI 1184617953

NPI Details

DR. Brian E Daikh, MD is a specialist in Portland, ME with 29 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Brian E Daikh, MD NPI is 1184617953. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

51 SEWALL ST
PORTLAND, ME
ZIP 04102-643
Phone: (207) 774-5761
Fax: (207) 874-7478

The NPI 1184617953 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Blood creatinine level (HCPCS:82565)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Uric acid level, blood (HCPCS:84550)
• Rheumatoid factor level (HCPCS:86431)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 8/26/2005 and was last updated on 12/5/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.